The RANKL expression induced by miR‐660‐5p was reversed as a result of SMARCA5 knockdown, indicating that miR‐660‐5p could play a role in bone‐specific metastasis of lung cancer cells by modulating RANKL signaling through targeting SMARCA5. Here, SMARCA5 is linked to lung carcinoma.